Skip to content

Other Working Capital at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$3.9M-160%
Alkermes logo
AlkermesALKS
-$717K-135%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$1.49M-13.2%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$0+100%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$0-100%
Biohaven logo
BiohavenBHVN
$837K-70.6%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.99B-14.9%

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashExpense.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s other working capital?
Harmony Biosciences Holdings, Inc. (HRMY) reported other working capital of $560K in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s other working capital changed year-over-year?
Harmony Biosciences Holdings, Inc.'s other working capital increased by 19.9% year-over-year, from $467K to $560K.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s other working capital?
Over 3 years (2022 to 2025), Harmony Biosciences Holdings, Inc.'s other working capital has grown at a -4.4% compound annual growth rate (CAGR), from $1.53M to $1.33M.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.